How do I contact Marco Boorsma?

Marco Boorsma, General Partner at Forbion, can be reached by email. The verified email address is listed on this page.

What is Marco Boorsma's email address?

Marco Boorsma's email address uses the forbion.com domain (shown as *****@forbion.com until revealed).

What does Marco Boorsma invest in?

Marco Boorsma backs Health tech companies at Series A and Seed, typically writing €92k–€4.6M cheques.

How do I cold email Marco Boorsma?

Marco Boorsma backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. A concise cold email that leads with relevant traction and one specific ask, sent to the verified address on this page, is the most direct way to reach Marco.

Where is Marco Boorsma based?

Marco Boorsma is based in Amsterdam, Netherlands and works at Forbion.

Marco Boorsma Email & Contact Information

General Partner @ Forbion

Show Marco's email

Marco Boorsma Location

Amsterdam, Netherlands

Marco Boorsma Investing

General Partner at Forbion

Stages: Series A, Seed
Sectors: Health tech
Cheque size: €92k–€4.6M
Freshness: Verified 1mo ago

Marco Boorsma Summary

Marco Boorsma, based in Amsterdam, Netherlands, is a General Partner at Forbion. Marco Boorsma invests in Health tech at Series A and Seed, writing €92k–€4.6M cheques. Marco Boorsma's verified email and contact details are available on Mintround.

How to cold email Marco Boorsma

Marco Boorsma, Forbion in Amsterdam, Netherlands, backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. Here's how to get a reply when you cold email Marco:

Subject line: name your company and one metric that matters to Health tech, not “quick chat”.
First line: your strongest traction, the real numbers, not adjectives.
One ask: a 20-minute call with a date range. Keep it under 150 words.
Send it to Marco's verified address below. No warm intro required.

Show Marco's email

Notable investments

Corsera HealthSeries A · $80M · 2026
Orbis MedicinesSeries A · $93M · 2025
Calluna PharmaSeries A · $81M · 2024
Inversago PharmaSeries C · $69M · 2022
NorthSea TherapeuticsSeries C · $80M · 2021
Rectify PharmaceuticalsSeries A · $100M · 2021
InflazomeSeries B · $46M · 2018
Milestone PharmaceuticalsSeries D · $80M · 2018

Frequently co-invests with

Ed Mathers (New Enterprise Associates (NEA))2×David SteinbergLongwood FundDebra K. LiebertDomain AssociatesDirk KerstenForbionEla BorensteinKauffman FellowsElizabeth DouvilleAmorchemEric LinsleyMission BioCapitalJason RhodesAtlas VentureJodie MorrisonAtlas VentureNanna LuneborgForbionOscar Slotboom (BGV (BioGeneration Ventures))Rajesh DevrajAtlas Venture

Marco Boorsma's colleagues at Forbion

Rogier RooswinkelPartner, Forbion

Sander SlootwegManaging Partner, Forbion

Wouter JoustraGeneral Partner, Forbion

Antoine Boulanger PietteAssociate, Forbion

Audrey CacalySenior Associate, Forbion

Dmitrij HristodorovPartner, Forbion

Dirk KerstenGeneral Partner, Forbion

Geert-Jan MulderManaging Partner, Forbion

Holger ReithingerGeneral Partner, Forbion

Jasper BosGeneral Partner, Forbion

Martien van OschManaging Partner, Forbion

Nanna LuneborgGeneral Partner, Forbion

See all 13 at Forbion →

Similar investors

Diede BrunenSenior Associate, BGV (BioGeneration Ventures)

Antoine Boulanger PietteAssociate, Forbion

Robin van BoxselPartner, FORWARD.one

Clement SalqueAnalyst, Bioqube Ventures